Quick Guide to Diabetes Mellitus
- 2nd Edition - March 1, 2026
- Authors: William Winter E, Brittany Bruggeman S, Laura Michelle Jacobsen, Timothy P. Foster
- Language: English
- Paperback ISBN:9 7 8 - 0 - 4 4 3 - 2 1 7 2 5 - 8
- eBook ISBN:9 7 8 - 0 - 4 4 3 - 2 1 7 2 4 - 1
Quick Guide to Diabetes Mellitus, Second Edition provides essential knowledge on the pathophysiology, etiology, epidemiology, diagnosis, laboratory evaluation, and basic clinical… Read more
Quick Guide to Diabetes Mellitus, Second Edition provides essential knowledge on the pathophysiology, etiology, epidemiology, diagnosis, laboratory evaluation, and basic clinical management of diabetes and its complications targeted to laboratory scientists and technicians. Eleven percent of the U.S. population have been diagnosed with diabetes mellitus, and laboratory scientists play an essential role in the diagnosis, monitoring, and management of this disease. This reference presents an easy-to-read question-and-answer format that will provide fundamental knowledge and aid in commonly encountered clinical challenges.
This updated release includes new information on genetic and environmental risk factors for type 1 and 2 diabetes, pediatric glucose targets per American Diabetes Association Standards, type 2 diabetes management sections, including treatment guidelines and information on glucagon-like peptide-1 receptor agonists and gastric bypass surgery.
- Provides a new section on the staging of pre-symptomatic type 1 diabetes
- Includes new coverage on diabetes-related exocrine pancreatic insufficiency
- Presents clear-and-concise information on the latest research in endocrinology
- Covers continuous glucose monitoring technology, including sensor methods and limitations
Laboratory scientists and technicians, as well as trainees and clinicians in the field of diabetes and endocrinology including fellows Students
1. Pathophysiology
2. Historical Context
3. Insulin Secretion and Action
4. Etiology
5. Type 1 Diabetes
6. Genetic Risk Factors
7. Environmental Risk Factors
8. Stages of Type 1 Diabetes
9. Type 2 Diabetes
10. Genetic Risk Factors
11. Environmental Risk Factors
12. Other Diabetes
13. Monogenic diabetes
14. Type 3c diabetes
15. Others
16. Epidemiology
17. Type 1 Diabetes
18. Type 2 Diabetes
19. Diagnosis & Ongoing Evaluation
20. Diagnostic criteria in adults & children
21. Diagnostic criteria in pregnancy
22. Testing considerations
23. Timing of screening
24. Glycated hemoglobin
25. Oral glucose tolerance testing
26. Fasting & random plasma glucose
27. Measuring Glucose in the Lab
28. Type 1 versus type 2 diabetes
29. Other tests
30. Diabetes Emergencies
31. Diabetic ketoacidosis
32. Hyperglycemic hyperosmolar state
33. Complications
34. Acute signs, symptoms, & complications
35. Chronic complications
a. Microvascular disease
b. Macrovascular disease
c. Neuropathy
d. Others
36. Clinical Management
37. Treatment goals
38. Self-monitoring of blood glucose
39. Capillary blood glucose
40. Continuous glucose monitors
41. Medical management
42. Type 1 diabetes
43. Type 2 diabetes
44. Associated risk factors
45. Conclusion
2. Historical Context
3. Insulin Secretion and Action
4. Etiology
5. Type 1 Diabetes
6. Genetic Risk Factors
7. Environmental Risk Factors
8. Stages of Type 1 Diabetes
9. Type 2 Diabetes
10. Genetic Risk Factors
11. Environmental Risk Factors
12. Other Diabetes
13. Monogenic diabetes
14. Type 3c diabetes
15. Others
16. Epidemiology
17. Type 1 Diabetes
18. Type 2 Diabetes
19. Diagnosis & Ongoing Evaluation
20. Diagnostic criteria in adults & children
21. Diagnostic criteria in pregnancy
22. Testing considerations
23. Timing of screening
24. Glycated hemoglobin
25. Oral glucose tolerance testing
26. Fasting & random plasma glucose
27. Measuring Glucose in the Lab
28. Type 1 versus type 2 diabetes
29. Other tests
30. Diabetes Emergencies
31. Diabetic ketoacidosis
32. Hyperglycemic hyperosmolar state
33. Complications
34. Acute signs, symptoms, & complications
35. Chronic complications
a. Microvascular disease
b. Macrovascular disease
c. Neuropathy
d. Others
36. Clinical Management
37. Treatment goals
38. Self-monitoring of blood glucose
39. Capillary blood glucose
40. Continuous glucose monitors
41. Medical management
42. Type 1 diabetes
43. Type 2 diabetes
44. Associated risk factors
45. Conclusion
- Edition: 2
- Published: March 1, 2026
- Language: English
WW
William Winter E
Dr. Winter is a professor of pathology, immunology, and laboratory medicine; pediatrics; and molecular genetics and microbiology at the University of Florida in Gainesville. He is principal investigator for the National Institutes of Health-funded Type 1 Diabetes TrialNet Islet Cell Autoantibody Core Laboratory and Islet Autoantibody Standardization Program. Dr. Winter directs the endocrine autoantibody laboratory that at the University of Florida, has given numerous presentations and has published extensively on behalf of the AACC. A multiple-time winner of the AACC outstanding speaker award, Dr. Winter has served on several AACC annual meeting organizing committees. He is a fellow of the College of American Pathologists and the National Academy of Clinical Biochemistry, which he served as a member of the board of directors. He has contributed more than 200 articles, chapters, and abstracts.
Affiliations and expertise
Professor, Departments of Pathology and Pediatrics, Medical Director, Clinical Laboratory Support Services (CLSC), Medical Director, Point-of-Care Testing (POCT)BB
Brittany Bruggeman S
Brittany Bruggeman, MD, is a board-certified pediatrician and pediatric endocrinologist and Diplomat, for the American Board of Pediatrics. Dr. Bruggeman received numerous scholarly awards. Most recently she received the 2020 Douglas J. Barrett, MD Academic Fellowship Award that recognizes pediatric clinicians or researchers for displaying the highest qualities in research, teaching and patient care. Dr. Bruggeman is a member of many professional organizations including the American Academy of Pediatrics, the American Diabetes Association and the Type 1 Diabetes TrialNet, an international network of endocrinologists at the forefront of Type 1 diabetes
Affiliations and expertise
Assistant Professor of Pediatric Endocrinology, University of Florida Health Shands Children’s Hospital, University of Florida, Gainesville, Florida, USALJ
Laura Michelle Jacobsen
Laura Jacobsen, MD, is an assistant professor and pediatric endocrinologist who joined the University of Florida faculty in 2018 in the department of pediatrics. She completed her pediatric residency training at the University of North Carolina in Chapel Hill, which was followed by a pediatric endocrinology fellowship at the UF Health Shands Children’s Hospital in Gainesville, Florida. During her fellowship, Dr. Jacobsen was recognized for her excellence in medical student teaching, and she received the Henry A. Kokomoor Outstanding Fellowship Award. Dr. Jacobsen provides clinical care for children with endocrine disorders and diabetes. She performs clinical and translational research in the field of Type 1 diabetes to better understand what causes Type 1 diabetes and ways to halt or prevent it.
Affiliations and expertise
Affiliate Assistant Professor with Graduate Faculty Status, Department of Pathology, Immunology, and Laboratory Medicine, University of Florida, Gainesville, Florida, USATF
Timothy P. Foster
Dr. Timothy P. Foster is a pediatric endocrinologist in Gainesville, Florida. He received his medical degree from Florida Atlantic University Charles E. Schmidt College of Medicine and has been in practice between 6-10 years. Pediatric endocrinologists treat disorders of the hormone-secreting glands that regulate countless body functions. These ailments include diabetes, thyroid ailments, metabolic and nutritional disorders and pituitary diseases. He has published
Affiliations and expertise
Pediatric Endocrinology Fellow, Department of Pediatrics, College of Medicine, University of Florida, USA.